Stock info Recordati | Filter  Basic-Info

Recordati

The past year was a profitable year for Recordati investors

Over the past year the company' stock gained around 12 percent. The period between August 2011 and August 2016 was a profitable period for the investors. The stock rose on average 378 percent. Recordati's revenues between 2011 and 2015 were quite unstable and moved between 828,32 million euros and 1,05 billion euros. During 2011 and 2015 Recordati's net results were very volatile and fluctuated between 116,45 million euros and 198,8 million euros.

The head office of Recordati is situated in Milano. Recordati is active in the pharmaceutical sector. The CEO of Recordati is Giovanni Recordati. Fritz Squindo is financially responsible for the company as CFO. The global pharmaceutical companies gained around 75 percent over the last 10 years. Measured since 2011 the sector is 147 percent higher and over the past 12 months (December 2015-2016) there is a minus of 75 percent.

The Italian company paid out dividends in the past 5 years. Over the past 5 years the stock delivered an average dividend return of 2,03 percent.

Recordati financed with relatively low debt

As per the end of 2015 the Italian company's balance sheet equaled 1,47 billion euros. Last year the total debt of the company was 598,98 million euros. This equals around 40,78 percent of the total balance sheet. At the end of 2016 the Italian company was traded with a price/earnings-ratio of around 13. So investors paid 13 times the company's 2015's EPS. We could say that based on her price/earnings-ratio and dividend yield the Italian stock can be seen as a value stock.

The pharmaceutical company's market capitalization (the number of shares outstanding times the market value) equaled around 4,94 billion euros. At the end of 2015 around 205,27 million stocks were listed.

All the company's financial reports are available here. More information about Recordati can be found it's website. .